Coeptis Therapeutics Inc.
COEPDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819663
Coeptis Therapeutics Inc. was delisted in 2022; its insiders filed their last Form 4 on Nov 18, 2021; no institution reported holding it in 13F filings for Q3 2022; no superinvestor held it.
Holders of 5% or more of COEP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Coeptis Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Coeptis Therapeutics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Coeptis Therapeutics Inc., newest first.
No Schedule 13D or 13G filings on Coeptis Therapeutics Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Coeptis Therapeutics Inc. shares.
No Form 144 notices for Coeptis Therapeutics Inc. are on file.